Viewing Study NCT05675033


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-01-24 @ 5:58 PM
Study NCT ID: NCT05675033
Status: UNKNOWN
Last Update Posted: 2023-01-09
First Post: 2022-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma
Sponsor: Fujian Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Adenocarcinoma View
None Stage IV Non-small Cell Lung Cancer View
None PD-1 Inhibitor View
None VEGF View
Keywords: